9.90
-0.48
(-4.58%)
As of 8:02:47 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 5 | 10 | 11 |
| Avg. Estimate | 4.47B | 4.85B | 19.29B | 20.65B |
| Low Estimate | 4.35B | 4.57B | 19.21B | 19.16B |
| High Estimate | 4.63B | 5.04B | 19.49B | 21.66B |
| Year Ago Sales | 5.11B | 5.2B | 22B | 19.29B |
| Sales Growth (year/est) | -12.57% | -6.64% | -12.30% | 7.05% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CVA.F | -- | -- | -- | -- |
| S&P 500 | 8.43% | 11.29% | 13.87% | 13.50% |
Upgrades & Downgrades
| Upgrade | GLJ Research: Sell to Buy | 1/7/2025 |
| Maintains | Citigroup: Neutral to Neutral | 12/19/2024 |
| Initiated | Goldman Sachs: Buy | 12/2/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 9/18/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 9/17/2024 |
| Maintains | Citigroup: Neutral to Neutral | 9/10/2024 |